Kedaara Capital backs India's Tynor Orthotics with $200M — a top-percentile health round
What's the deal? Kedaara CapitalDealroom has a profile for this one. Try Dealroom → has invested $200 million in Tynor OrthoticsDealroom has a profile for this one. Try Dealroom →, an India-based maker of orthopaedic supports, mobility aids, and rehabilitation solutions. Kedaara led the late-stage round, announced in August 2026.
The scale: The deal ranks in the top 1% of all late-stage venture rounds in India's health sector by size, based on a sample of 105 comparable deals. That places Tynor among the largest health raises the country has recorded.
What does Tynor do? Founded in 1993, the company sells orthopaedic supports, mobility aids, and sports performance products through more than 300,000 retail outlets and 8,000 hospitals across 60 countries. It says its products have reached over 100 million people. Tynor runs three manufacturing facilities using lean production for domestic and export markets.
What's the endgame? Kedaara will work with promoters Dr P.J. Singh and A.J. Singh, the management team, and long-standing partner ThuasneDealroom has a profile for this one. Try Dealroom → to expand Tynor at home and abroad. The plan focuses on strengthening manufacturing and building the company into a global orthotics and wellness platform.
Why now? Sunish Sharma, founder and managing partner at Kedaara, called India's medical devices sector "among the fastest-growing globally" and described Tynor as a category leader. The deal ends Lighthouse FundsDealroom has a profile for this one. Try Dealroom →' eight-year partnership with the company.
What they're saying: "We are privileged to partner with them and Thuasne to unlock Tynor's full potential," Sharma said. The promoters said the partnership supports their ambition to lead in the Global South and become a key supply-chain partner for the Global North.
The signal: A $200 million cheque into a device maker underscores investor appetite for India's medical manufacturing, where established distribution and export reach — not just software scale — are drawing large late-stage capital.
Read more: fortuneindia.com
Image credit: Tynorindia
